Maze Therapeutics revenue was $20.00M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $20.0M, up Infinity% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MAZE annual revenue was $0.0, with -100% growth year-over-year.
MAZE past revenue growth
How has MAZE's revenue growth performed historically?
Maze Therapeutics (NASDAQ: MAZE) reported Q1 2026 revenue of $20.00 million up Infinity% year over year. In the same quarter last year, Maze Therapeutics's revenue was $0.00.
What was Maze Therapeutics's revenue in 2025?
Maze Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.
How much does Maze Therapeutics make in a day?
Based on Maze Therapeutics annual revenue for the past three years, MAZE makes an average of $152,968.04 per day.
What was Maze Therapeutics's annual revenue growth in the past year?
As of Q2 2026, Maze Therapeutics's revenue has grown -88.06% year over year. This is 330.26 percentage points lower than the US Biotechnology industry revenue growth rate of 242.2%. Maze Therapeutics's revenue in the past year totaled $20.00 million.
How much does Maze Therapeutics make in a year?
Maze Therapeutics's revenue by year for the past three years is:
Maze Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $0.00, a 100% decrease year over year.
Maze Therapeutics's annual revenue for Dec 31, 2024 was $167.50 million, a Infinity% increase from 2023.
Maze Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.